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ABSTRACT
The objective of this study was to assess the perceived utility of an
educational resource booklet addressing the psychiatric manifestations and
mental health considerations within 22q11.2 deletion syndrome (22q11.2DS).
Seventy-three parents of children with 22q11.2DS completed online
surveys before and after reading the booklet. The surveys assessed personality
factors and feelings of empowerment, worry, self-stigma, and ability to tolerate
uncertainty.
Participants reported that the booklet was easy to understand, provided
better understanding of 22q11.2DS and mental illness, answered questions
about mental illness associated with the condition, improved knowledge of
strategies for protecting the mental health of children with the condition, raised
confidence levels in recognizing early warning signs of mental illness, and would
be helpful for other families with children affected by the condition. Participants’
feelings of empowerment increased by the end of the process while feelings of
worry decreased. It was reported that the information contained in the booklet
would be beneficial to receive at the time of the diagnosis.
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The participants had overall high satisfaction with the booklet. Their
knowledge and understanding of mental health within 22q11.2DS reportedly
increased after viewing the booklet. The study results suggest a potential benefit
in distributing this educational resource to other parents of children with
22q11.2DS.
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CHAPTER 1
LITERATURE REVIEW
1.1 22q11.2 deletion syndrome background
With an estimated prevalence of 1 in 2,000 to 1 in 4,000 live births,
22q11.2 deletion syndrome (22q11.2DS) is the most common microdeletion
syndrome (Bassett et al., 2011; Fung et al., 2015). The condition shows variable
expression among individuals with a heterogeneous manifestation of symptoms
and features. These include congenital heart defects (CHD), immunodeficiency,
hypoparathyroidism, cleft palate, psychiatric illness, developmental delay,
intellectual disability, learning disability, characteristic facial features, behavioral
differences, and hypernasal speech (Bassett et al., 2011; McDonald-McGinn et
al., 2015). The syndrome has been termed the second leading cause of major
congenital heart disease and developmental delay. It accounts for an estimated
10-15% of individuals with tetralogy of Fallot and 2.4% of people with
developmental disabilities (Bassett et al., 2011).
Most cases of 22q11.2DS (90-95%) are newly occurring, or de novo
(McDonald-McGinn et al., 2015). In the remainder of cases, the condition is
inherited from a parent in an autosomal dominant fashion with a 50% chance of
the parent passing on the condition to their child. As the medical management of
the condition improves, the percentage of inherited cases may increase in the
future (McDonald-McGinn et al., 2015). The cause of 22q11.2DS is most
1

commonly (85%) a large, 3 Mb deletion on the long arm of chromosome 22
which is a region containing approximately 45 functional genes (Bassett et al.,
2011). Smaller, atypical, or ‘nested’ deletions within this region account for other
cases. The deletions leading to the features observed in 22q11.2DS can range
between 0.7 Mb to 3 Mb in size. They occur due to homologous sequences in
low copy repeat sequences (LCR) throughout this region (Babcock et al., 2003;
Bailey et al., 2002). Due to the similarity of the LCRs, errors are enabled where
the LCRs align incorrectly with each other during nonallelic homologous
recombination in meiosis. This causes aberrant crossover events that lead to the
loss of genetic material (Babcock et al., 2003; Bailey et al., 2002).
Genetic differences causing 22q11.2DS can be identified typically through
fluorescent in situ hybridization (FISH), multiplex ligation-dependent probe
amplification (MLPA), or array comparative genomic hybridization (aCGH). When
a child has 22q11.2DS, parents may be offered genetic testing to confirm if the
deletion is inherited or de novo due to the variable expressivity of the condition
(Bassett et al., 2011).
1.2 22q11.2DS manifestations
Common manifestations of 22q11.2DS include developmental delay,
congenital anomalies, and medical and psychiatric disorders with varying ages of
onset. Patients typically have at least one prominent phenotypic feature of the
condition (Fung et al., 2015). The most prevalent features reported in
approximately 75% include congenital heart defects, immunodeficiency, and
palatal abnormalities. Hypocalcemia and gastrointestinal issues (including
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feeding and swallowing difficulties) are reported in approximately 50%, and
genitourinary anomalies (such as renal agenesis) are described in approximately
30% (McDonald-McGinn et al., 2015). Characteristic facial features (bulbous
nose, micrognathia, asymmetric crying facies, nasal dimple, and hooded eyelids),
hypernasal speech, language delays, learning disabilities, short stature, hearing
loss, and seizures can also be present in affected individuals (McDonald-McGinn
et al., 2015).
Cardiac defects are considered the leading cause for mortality of children
with 22q11.2DS, accounting for around 87% of deaths in this stage of life
(McDonald-McGinn et al., 2015). Identification of these heart abnormalities may
lead to an individual's diagnosis and can sometimes be detected in the prenatal
or neonatal period. In addition to cardiac defects, immune system anomalies are
also prevalent within the syndrome, most commonly presenting as recurrent
infections (35-40%), autoimmune diseases, and low and impaired T-cell function
(Bassett et al., 2011). Palatal abnormalities often manifest in a mild manner
(65%), presenting as bifid uvula, velopharyngeal dysfunction, or occult
submucosal cleft palate. Around 11% of pediatric patients with 22q11.2DS have
overt cleft palate (McDonald-McGinn et al., 2015).
Other features described in 22q11.2DS include hypoparathyroidism,
gastrointestinal anomalies, and genitourinary anomalies. Hypoparathyroidism
within the condition is thought to lead to hypocalcemia, occurring in over 50 to
60% of cases. Hypocalcemia may result in symptoms of stridor, tetany, fatigue,
feeding difficulty, and seizures (McDonald-McGinn et al., 2015). Gastrointestinal
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anomalies affect around 30% of individuals with 22q11.2DS. Difficulties in
swallowing and feeding, if severe, can necessitate placement of a feeding tube
(McDonald-McGinn et al., 2015). Additional anomalies may be present in the
genitourinary system which can present as cryptorchidism, absent uterus,
dysplastic or cystic kidneys, inguinal hernia, hydronephrosis, or hypospadias.
Around one-third of patients will have one genitourinary feature (McDonaldMcGinn et al., 2015).
Developmental delay is another feature of 22q11.2DS. In an estimated
70% of cases involving affected children, there is a delay in language onset
resulting in either a deficit in words used by the age of 24 months or a nonverbal
state (McDonald-McGinn et al., 2015). There is also a difference in intelligence
quotient (IQ) scores between the general population and patients with the
condition. The average IQ of an individual with 22q11.2DS is around 70, whereas
the average IQ for the general population is 100 (McDonald-McGinn et al., 2015).
Mild intellectual disabilities occur in around 30-40% of cases (Fung et al., 2015).
Severe intellectual disabilities appear to be uncommon among affected
individuals, but children experiencing prolonged hypocalcemia, cardiac arrest,
neonatal seizures, or primary brain malformations tend to have poorer cognitive
outcomes (McDonald-McGinn et al., 2015). Mathematics and language
comprehension appears to be the most prevalent areas where learning
difficulties are present for preschool to elementary school aged patients
(McDonald-McGinn et al., 2015).
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Another prominent manifestation of 22q11.2DS is psychiatric illness.
Psychiatric illnesses are considered the most common later-onset conditions in
22q11.2DS (Fung et al., 2015). Their prominence and impact make them the
most highly reported point of concern among patients and their families. These
manifestations are the most likely among the adolescent and adult population to
require medical attention and affect the daily life of the individual (Fung et al.,
2015). The most prevalent psychiatric conditions experienced by patients with
22q11.2DS are schizophrenia (25% of adults), autism (20% of children), anxiety
(24-56% of adults), mood disorders (18-41% of adults), and attentiondeficit/hyperactivity disorder (ADHD; 22-33% of adolescence) (Biswas & Furniss,
2016; McDonald-McGinn et al., 1999). Obsessive-compulsive disorder (OCD)
can also be observed in some cases (Biswas & Furniss, 2016). With a nearly 20fold increased chance for schizophrenia (SCZ), this makes the 22q11.2 deletion
the most prominent molecular genetic risk factor for this psychiatric illness (Fung
et al., 2015; McDonald-McGinn et al., 2015).
1.3 22q11.2DS management
Due to the variable expressivity of 22q11.2DS causing a wide spectrum of
symptoms and manifestations, management must be tailored to address patientspecific needs. This customized management allows for the most effective
treatment for the patient’s features, severity, age or developmental stage, and
need for treatment (Bassett et al., 2011). Common management typically
involves specialties and services including pediatrics, surgery, general medicine,
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interventional therapies, psychiatry, psychology, and genetics services such as
consultations with a geneticist and genetic counselor (McDonald-McGinn et al.,
2015).
The cardiac manifestations are typically treated as they would be in an
individual without 22q11.2DS, and surgical intervention is pursued when required
for repair of a congenital heart defect. Special considerations might include
increased attention to preventing hypocalcemia, bronchospasm and airway
bleeding, and immunological depression around the time of the surgery
(McDonald-McGinn et al., 2015). Many adult patients who previously underwent
intracardiac repair during childhood require repeat cardiac interventions and
follow-up (Fung et al., 2015).
Immune system dysfunction in 22q11.2DS patients requires testing to
determine the exact cause of the abnormality. Depending on the severity, a
thymus transplant may be required; however, it is not typical for the transplant
stage to be reached (McDonald-McGinn et al., 2015). If a low T-cell count is
discovered, isolation is recommended for the patient's safety, and live viral
vaccines are not administered. Allergies and recurrent infections are corrected
through sinus rinses, ear tubes, and allergy treatment (McDonald-McGinn et al.,
2015).
Additional areas for treatment and management include those for palatal
anomalies, gastrointestinal anomalies, and genitourinary complications.
Treatment for palatal anomalies for patients with 22q11.2DS is usually identical
to that of a patient without the condition. Surgical repair is typically pursued when
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the patient is about 4 to 6 years of age. This repair allows for an improved quality
of life by enabling normal speech production and effective communication
(McDonald-McGinn et al., 2015). For gastrointestinal anomalies, a feeding tube
may be necessary for more extreme feeding and swallowing difficulties. For
genitourinary complications, consultation with a nephrologist, urologist, or
gynecologist may be appropriate (McDonald-McGinn et al., 2015).
Another point of management includes treating thyroid dysfunction and
hypocalcemia. Calcium levels in patients should be monitored in infancy to avoid
seizures. In addition, surveillance for calcium levels should be completed when
the patient is experiencing biological stress, such as puberty, pregnancy,
delivery, or before an operation (McDonald-McGinn et al., 2015). Thyroid function
should also be assessed annually in adult patients. Appropriate thyroid
medication or calcium and vitamin D supplements may be recommended if
necessary (McDonald-McGinn et al., 2015).
Cognitive differences in 22q11.2DS may also entail specific management
recommendations depending on areas of concern and severity. Accommodations
such as assistance with managing money, completing forms, and making
complex life and work decisions may be necessary (Fung et al., 2015). Deficits in
verbal learning can be addressed through visual reminders, which have been
found to reduce the frustrations of both caregivers and patients (Fung et al.,
2015). Throughout the lifespan of a patient with 22q11.2DS, sign language,
educational supports, early intervention, and vocational counseling serve as
management strategies for the cognitive differences (Bassett et al., 2011).
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When individuals experience psychiatric illness as a part of 22q11.2DS, it
is most effectively treated when detected and managed early (Gothelf et al.,
2007). Therefore, timely detection of psychiatric illness is essential in providing
effective management. In a study by Weisman et al. (2017), research was
conducted to examine subthreshold psychosis in patients (ranging from 6-55
years old with an average age of 17.1) with 22q11.2DS. It was found that the
highest rate of subthreshold psychosis occurred in the age range of 13-25 years
old. Additionally, individuals with these symptoms were found to have higher
rates of anxiety disorders and ADHD and were found to have lower IQ and global
functioning scores (Weisman et al., 2017). In another study, Gothelf et al. (2007)
researched risk factors regarding psychotic disorders in patients with 22q11.2DS.
This study involved affected and unaffected children, both around 12 years old.
An internal longitudinal comparison was completed of the two groups when they
reached 16-17 years old. At the follow-up, 32.1% of affected individuals had
developed psychotic disorders compared to 4.3% of the unaffected individuals
(Gothelf et al., 2007). The main predictors for this development were anxiety and
OCD in childhood. Similarly, low verbal IQ in childhood was suggested to be a
risk factor for psychotic disorders among individuals with 22q11.2DS (Gothelf et
al., 2007). This data supports early identification and intervention for children with
these subthreshold signs of psychosis which may help improve the prognosis
and outcome of patients.
Additionally, it is recommended that changes in behavior, functioning,
thinking, physical state, and emotion be monitored routinely for individuals with
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22q11.2DS who have a mental health condition. A knowledgeable clinician
should perform this monitoring due to the possibility of communication difficulties
with patients who have moderate to severe intellectual disability (Fung et al.,
2015). Treatment is similar to those with psychiatric illness without 22q11.2DS
(Bassett et al., 2011). Changes such as avoidance of substance use, eating a
healthy diet, and implementing mental and physical exercise serve as
recommendations that might help reduce the chance for psychiatric illness (Fung
et al., 2015).
Another form of management for patients with 22q11.2DS is genetic
counseling. Recommendations for individuals with the condition include receiving
multiple appointments with genetic counselors throughout their lives to obtain
information about their condition (Fung et al., 2015). This information would
include discussions about the inheritance pattern and recurrence risk, etiology,
variability, medical and psychiatric manifestations, and interventions (Bassett et
al., 2011).
1.4 Previous studies on psychiatric illness in 22q11.2DS and parent
education
Although patients with 22q11.2DS have a higher chance of experiencing
psychiatric conditions, the affected adolescent population is no more likely to
receive mental health care than the general, age-matched population (Young et
al., 2011). It has been reported that early intervention may reduce the risk of
developing a psychotic disorder (Gothelf et al., 2007). Studies have been
completed looking at subthreshold indicators for psychosis in patients with
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22q11.2DS. Anxiety disorders, low IQ scores, ADHD, and OCD have been
associated with later onset psychosis in these patients (Gothelf et al., 2007;
Weisman et al., 2017). An information deficit exists among parents of children
with 22q11.2DS regarding the increased chance for mental illness. Parents
typically receive information about the nonpsychiatric manifestations of the
condition from healthcare providers, but they do not always receive information
regarding the psychiatric manifestations. Parents often report obtaining
information about this aspect of the condition through nonmedical sources such
as the internet (61.5%) (Hercher & Bruenner, 2008).
Interestingly, psychiatric presentations are reported to invoke greater
anxiety levels among parents than medical presentations (Hercher & Bruenner,
2008). A study found that the possibility of psychiatric illness was not shared at
the time of diagnosis for most cases (only 38.5% had received this information
during the diagnosis), and it was not frequently brought up later by healthcare
providers such as pediatricians (only 2.6% received this information from the
pediatrician) (Hercher & Bruenner, 2008). This remained true for medical
geneticists, with only 38.1% of parents reporting that they received information
about their child’s chance of developing a psychiatric illness from a medical
geneticist. This is concerning considering this manifestation of the condition is
deemed to have a high perceived burden among caregivers and patients
themselves (Karas et al., 2014). The reason behind this deficit in knowledge
surrounding the psychiatric manifestations of the condition was explored in a
later study. Through a questionnaire and parent interviews, it was found that
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genetic counselors felt that the risk for psychiatric illness was important to report;
however, they were significantly less likely to discuss this risk than they were to
discuss risks for other possible features of the condition (41% versus 83%,
respectively) when the initial counseling session took place when the patient was
an infant (Martin et al., 2012). When asked about the appropriate time for
disclosing the psychiatric risk, the genetic counselors answered incongruently
with a wide spectrum across infancy, childhood, and adolescence (Martin et al.,
2012). This increases the chance that the information may miss being reported
since there is no standardized delivery time. The small sample of parents in the
study (n = 4) expressed that they preferred to know about the psychiatric risks
before the onset of their child’s symptoms (Martin et al., 2012). In a more
extensive study with parents (n = 37) of children with 22q11.2DS, it was
determined that the parents wanted to learn more about preventing or coping
with their child’s mental health complications (Alugo et al., 2017). The parents
also gave suggestions regarding information that should be included in an
educational resource. They proposed including education regarding early
warning signs of psychiatric illness, talking with their child about the condition,
and managing their child’s mental illness (Alugo et al., 2017). This need could be
met with psychiatric genetic counseling, but there is currently limited availability
of this specialized service (Inglis et al., 2015).
There are various examples of the use of educational booklets to
supplement topics discussed in genetic counseling sessions. Written educational
materials have been produced for genetic conditions such as cystic fibrosis,
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Down syndrome, and hereditary breast cancer (Bryant et al., 2001; Clayton et al.,
1995; Mancini et al., 2006; Vadaparampil et al., 2011). In a study by Lewis et al.
(2012), an informational booklet was created and evaluated for parents of
children who have not yet received a diagnosis for conditions with suspected
genetic etiologies. A booklet to support the psychosocial needs of the parents
was made through the combination of parent interviews, professional focus
groups, and a review of the literature. The booklet was then evaluated through a
questionnaire that assessed the relevance, usefulness, and scope of the
information. It was found that the parents had a high patient satisfaction score
with the information offered in the booklet (Lewis et al., 2012). Another study by
Hunt et al. (2020), used a written informational resource to increase parent
knowledge surrounding the inheritance and causation of congenital heart
disease. The brochure was piloted with a small group of parents of children with
congenital heart disease. It was then further evaluated with a larger sample size.
During the study, the parents answered questionnaires before and after viewing
the brochure. It was found that the resource increased the parents’ knowledge
regarding the causation of congenital heart disease, and many parents reported
a reduced feeling of guilt after viewing the resource (Hunt et al., 2020).
1.5 Research trajectory
This study aims to evaluate the use of an educational resource that
describes the psychiatric manifestations of 22q11.2DS to bridge the knowledge
deficit expressed by parents of children with the condition. The educational
material is in the form of a booklet designed by a University of British Columbia
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(UBC) genetic counseling candidate in collaboration with the UBC Department of
Psychiatry’s psychiatric genetic counseling team (Chieffo, 2018). An existing
written mental health resource inspired the booklet’s content with additional
direction provided by the input of parents of children with 22q11.2DS. The
booklet contains a description of 22q11.2DS and information about mental
illnesses. It provides an overview of mental illness, the causes, protective factors,
early detectable signs, mental health resources, and mental illness as seen in
22qDS. The current study assessed the utility of the resource, and it evaluated
the perceived changes in the parents’ feelings of empowerment, worry, and selfstigma surrounding the content. Parents were asked to complete surveys
relevant to their experience before and after viewing the resource. Based on the
results of this study, it may suggest a benefit in distributing this booklet to other
parents of children with 22q11.2DS. This will allow parents to access a
professionally developed resource rather than finding information through
unregulated sources such as the internet. The resource discusses multiple
previously identified parent concerns by addressing the condition's etiology and
highlighting signs of emerging mental illness. It also provides information about
mental health resources for the families.
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CHAPTER 2
EVALUATION OF THE PERCEIVED BENEFIT OF A PSYCHIATRIC
RESOURCE FOR PARENTS OF CHILDREN WITH 22Q11.2 DELETION
SYNDROME1

1Blankenship,

K., Prijoles, E., Batallones, R., Slomp, C., Morris, E., HillChapman, C., and Austin, J. To be submitted to Patient Education and
Counseling
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2.1 Abstract
2.1.1 Objectives
The objective of this study was to assess the perceived utility of an
educational resource booklet addressing the psychiatric manifestations and
mental health considerations within 22q11.2 deletion syndrome (22q11.2DS).
2.1.2 Methods
Seventy-three parents of children with 22q11.2DS completed online
surveys before and after reading the booklet. The surveys assessed personality
factors and feelings of empowerment, worry, self-stigma, and ability to tolerate
uncertainty.
2.1.3 Results
Participants reported that the booklet was easy to understand, provided
better understanding of 22q11.2DS and mental illness, answered questions
about mental illness associated with the condition, improved knowledge of
strategies for protecting the mental health of children with the condition, led to
raised confidence levels in recognizing early warning signs of mental illness, and
would be helpful for other families with children affected by the condition.
Participants’ feelings of empowerment increased by the end of the process while
feelings of worry decreased. It was reported that the information contained in the
booklet would be beneficial to receive at the timing of the diagnosis.
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2.1.4 Conclusions
The participants had overall high satisfaction with the booklet. Their
knowledge and understanding of mental health within 22q11.2DS reportedly
increased after viewing the booklet.
2.1.5 Practice Implications
The study results suggest a potential benefit in distributing this educational
resource to other parents of children with 22q11.2DS.
2.2 Introduction
With an estimated prevalence of 1 in 2,000 to 1 in 4,000 live births,
22q11.2 deletion syndrome (22q11.2DS) is the most common microdeletion
syndrome (Bassett et al., 2011; Fung et al., 2015). The condition shows variable
expression among individuals with a heterogeneous manifestation of symptoms
and features. These include congenital heart defects (CHD), immunodeficiency,
and palatal abnormalities in approximately 75% of individuals. Hypocalcemia and
gastrointestinal issues (including feeding and swallowing difficulties) are reported
in approximately 50%, and genitourinary anomalies such as renal agenesis are
described in approximately 30% (McDonald-McGinn et al., 2015). Characteristic
facial features (bulbous nose, micrognathia, asymmetric crying facies, nasal
dimple, and hooded eyelids), hypoparathyroidism, psychiatric illness,
developmental delay, intellectual disability, learning disability, behavioral
differences, seizures, hearing loss, and hypernasal speech can also be present
in affected individuals (Bassett et al., 2011; McDonald-McGinn et al., 2015). The
syndrome has been termed the second leading cause of major congenital heart
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disease and developmental delay. It accounts for an estimated 10-15% of
individuals with tetralogy of Fallot and 2.4% of people with developmental
disabilities (Bassett et al., 2011).
Most cases of 22q11.2DS (90-95%) are newly occurring, or de novo
(McDonald-McGinn et al., 2015). In the remainder of cases, the condition is
inherited from a parent in an autosomal dominant fashion with a 50% chance of
the parent passing on the condition to their child. As the medical management of
the condition improves, the percentage of inherited cases may increase in the
future (McDonald-McGinn et al., 2015). The cause of 22q11.2DS is most
commonly (85%) a large, 3 Mb deletion on the long arm of chromosome 22,
which is a region containing approximately 45 functional genes (Bassett et al.,
2011). Smaller, atypical, or ‘nested’ deletions within this region account for other
cases. Genetic differences causing 22q11.2DS can be identified typically through
genetic testing. When a child has 22q11.2DS, parents may be offered genetic
testing to confirm if the deletion is inherited or de novo due to the variable
expressivity of the condition (Bassett et al., 2011).
A prominent manifestation of 22q11.2DS is psychiatric illness. Psychiatric
illnesses are considered the most common later-onset conditions in 22q11.2DS
(Fung et al., 2015). Their prominence and impact make them the most highly
reported point of concern among patients and their families. These
manifestations are the most likely among the adolescent and adult population to
require medical attention and affect the daily life of the individual (Fung et al.,
2015). The most prevalent psychiatric conditions experienced by patients with
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22q11.2DS are schizophrenia (25% of adults), autism (20% of children), anxiety
(24-56% of adults), mood disorders (18-41% of adults), and attentiondeficit/hyperactivity disorder (ADHD; 22-33% of adolescence) (Biswas & Furniss,
2016; McDonald-McGinn et al., 1999). Obsessive-compulsive disorder (OCD)
can also be observed in some cases (Biswas & Furniss, 2016). With a nearly 20fold increased chance for schizophrenia (SCZ), this makes the 22q11.2 deletion
the most prominent molecular genetic risk factor for this psychiatric illness (Fung
et al., 2015; McDonald-McGinn et al., 2015).
When individuals experience psychiatric illness as a part of 22q11.2DS, it
is most effectively treated when detected and managed early (Gothelf et al.,
2007). Therefore, timely detection of psychiatric illness is essential in providing
effective management. In a study by Weisman et al. (2017), research was
conducted to examine subthreshold psychosis in patients (ranging from 6-55
years old with an average age of 17.1) with 22q11.2DS. It was found that the
highest rate of subthreshold psychosis occurred in the age range of 13-25 years
old. Additionally, individuals with these symptoms were found to have higher
rates of anxiety disorders and ADHD and were found to have lower IQ and global
functioning scores (Weisman et al., 2017). In another study, Gothelf et al. (2007)
researched risk factors regarding psychotic disorders in patients with 22q11.2DS.
This study involved affected and unaffected children, both around 12 years old.
An internal longitudinal comparison was completed of the two groups when they
reached 16-17 years old. At the follow-up, 32.1% of affected individuals had
developed psychotic disorders compared to 4.3% of the unaffected individuals
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(Gothelf et al., 2007). The main predictors for this development were anxiety and
OCD in childhood. Similarly, low verbal IQ in childhood was suggested to be a
risk factor for psychotic disorders among individuals with 22q11.2DS (Gothelf et
al., 2007). This data supports early identification and intervention for children with
these subthreshold signs of psychosis which may help improve the prognosis
and outcome of patients.
Additionally, it is recommended that changes in behavior, functioning,
thinking, physical state, and emotion be monitored routinely for individuals with
22q11.2DS who have a mental health condition. Treatment is similar to those
with psychiatric illness without 22q11.2DS (Bassett et al., 2011). Changes such
as avoidance of substance use, eating a healthy diet, and implementing mental
and physical exercise serve as recommendations that might help reduce the
chance for psychiatric illness (Fung et al., 2015).
Another form of management for patients with 22q11.2DS is genetic
counseling. Recommendations for individuals with the condition include receiving
multiple appointments with genetic counselors throughout their lives to obtain
information about their condition (Fung et al., 2015). This information would
include discussions about the inheritance pattern and recurrence risk, etiology,
variability, medical and psychiatric manifestations, and interventions (Bassett et
al., 2011).
Although patients with 22q11.2DS have a higher chance of experiencing
psychiatric conditions, the affected adolescent population is no more likely to
receive mental health care than the general, age-matched population (Young et
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al., 2011). This indicates a possible information deficit among parents of children
with 22q11.2DS regarding the increased chance for mental illness. Parents
typically receive information about the nonpsychiatric manifestations of the
condition from healthcare providers, but they do not always receive information
about the psychiatric manifestations. Parents often report obtaining information
about this portion of the condition through nonmedical sources such as the
internet (61.5%) (Hercher & Bruenner, 2008).
Interestingly, psychiatric presentations of 22q11.2DS are reported to
invoke greater anxiety levels among parents than medical presentations (Hercher
& Bruenner, 2008). However, a study found that the possibility of psychiatric
illness was not shared at the time of diagnosis for most cases (only 38.5% had
received this information during the diagnosis), and it was not frequently brought
up by later healthcare providers such as pediatricians (only 2.6% received this
information from the pediatrician) (Hercher & Bruenner, 2008). This remained
true for medical geneticists, with only 38.1% of parents reporting that they
received information about their child’s chance of developing a psychiatric illness
from a medical geneticist. This is concerning considering this manifestation of the
condition is deemed to have a high perceived burden among caregivers and
patients themselves (Karas et al., 2014). The reason behind the deficit in
knowledge surrounding the psychiatric manifestations of the condition was
explored in a later study. Through a questionnaire and parent interviews, it was
found that genetic counselors felt that the risk for psychiatric illness was
important to report; however, they were significantly less likely to discuss this risk
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than they were to discuss risks for other possible features of the condition (41%
versus 83%, respectively) when the initial counseling session took place when
the patient was an infant (Martin et al., 2012). When asked about the appropriate
time for disclosing the psychiatric risk, the genetic counselors answered
incongruently with a wide spectrum across infancy, childhood, and adolescence
(Martin et al., 2012). This increases the chance that the information may miss
being reported since there is no standardized delivery time. The small sample of
parents in the study (n = 4) expressed that they preferred to know about the
psychiatric risks before the onset of their child’s symptoms (Martin et al., 2012).
In a more extensive study with parents of children with 22q11.2DS (n = 37), it
was determined that the parents wanted to learn more about preventing or
coping with their child’s mental health complications (Alugo et al., 2017). The
parents also gave suggestions regarding information that should be included in
an educational resource. They proposed including education regarding early
warning signs of psychiatric illness, talking with their child about the condition,
and managing their child’s mental illness (Alugo et al., 2017). This need could be
met with psychiatric genetic counseling, but there is currently limited availability
of this specialized service (Inglis et al., 2015).
Educational booklets have been used in various medical settings to
address knowledge deficits surrounding certain conditions. There are numerous
examples of the use of educational booklets to supplement topics discussed in
genetic counseling sessions. Written educational materials have been produced
for genetic conditions such as cystic fibrosis, Down syndrome, and hereditary
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breast cancer (Bryant et al., 2001; Clayton et al., 1995; Mancini et al., 2006;
Vadaparampil et al., 2011). In a study by Lewis et al. (2012), an informational
booklet was created and evaluated for parents of children who have not yet
received a diagnosis for conditions with suspected genetic etiologies. A booklet
to support the psychosocial needs of the parents was made through the
combination of parent interviews, professional focus groups, and a review of the
literature. The booklet was then evaluated through a questionnaire that assessed
the relevance, usefulness, and scope of the information. It was found that the
parents had a high patient satisfaction score with the information offered in the
booklet (Lewis et al., 2012). Another study by Hunt et al. (2020), used a written
informational resource to increase parent knowledge surrounding the inheritance
and causation of congenital heart disease. The brochure was piloted with a small
group of parents of children with congenital heart disease. It was then further
evaluated with a larger sample size. During the study, the parents answered preand post-questionnaires before and after viewing the brochure. It was found that
the resource increased the parents’ knowledge regarding the causation of
congenital heart disease, and many parents reported a reduced feeling of guilt
after viewing the resource (Hunt et al., 2020).
This study aimed to evaluate the parent perception of an educational
resource addressing the psychiatric manifestations of 22q11.2DS. If successful,
this resource could aid in bridging the knowledge deficit surrounding parent
knowledge of psychiatric conditions involved in 22q11.2DS. The educational
material is in the form of a booklet designed by a University of British Columbia
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(UBC) genetic counseling candidate in collaboration with the UBC Department of
Psychiatry’s psychiatric genetic counseling team (Chieffo, 2018). An existing
written mental health resource inspired the booklet’s content with additional
direction provided by the input of parents of children with 22q11.2DS. The
booklet contains a description of 22q11.2DS and information about mental
illnesses. It provides an overview of mental illness, the causes, protective factors,
early detectable signs, mental health resources, and mental illness as seen in
22q11.2DS.
2.3 Materials and Methods
2.3.1 Participants and Recruitment
Parents of children diagnosed with 22q11.2 deletion syndrome were
recruited to participate in the study. Due to limitations in translation services, the
recruited parents were English-speaking. Recruitment occurred through two
methods, including the online distribution of a flyer by social media posts and a
patient letter sent directly to the parents of children affected with the condition.
Multiple 22q11.2 deletion syndrome support groups were contacted to aid in
distributing the online flyer. Communications were sent successfully to the 22q
Family Foundation, 22q and You Center (associated with the Children’s Hospital
of Philadelphia), and multiple individually run state support groups in the states of
South Carolina, California, Maryland, New Hampshire, New Jersey, Ohio,
Pennsylvania, and Texas. In addition, patient letters were sent to parents of
children seen through the Greenwood Genetic Center in South Carolina.
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2.3.2 General Procedure and Ethics
The study was conducted through online questionnaires which were
completed before, immediately after, and one month after reading an educational
booklet containing information about the psychiatric manifestations of 22q11.2
deletion syndrome. These questionnaires were referred to as the Pre-Resource
Viewing Questionnaire (T1), Immediate Post-Viewing Survey, and One Month
Post-Viewing Questionnaire (T2), respectively. The Pre-Resource Viewing
Questionnaire contained a combination of validated scales including the MiniInternational Personality Item Pool (Mini-IPIP), Intolerance of Uncertainty Short
Version (IUS Short Version), Problem-Focused Style of Coping (PF-SOC),
Genetic Counseling Outcome Scale (GCOS), Self-Stigma in Relatives of People
with Mental Illness Scale (SSRMI; participants only completed this section of the
questionnaire if they reported that their child had a mental illness), and Worry
scale (adapted from the modified cancer worry scale) (Carleton et al., 2007;
Donnellan et al., 2006; Douma, 2010; Heppner et al., 1995; McAllister et al.,
2011). The Immediate Post-Viewing Questionnaire included a question asking if
the participants completed the booklet, a question asking how long it took them
to complete the booklet, seven 5-point Likert scale questions (with 1 = “strongly
agree” and 5 = “strongly disagree”) assessing the participants’ perceptions of the
resource, and six short answer questions asking the participants for their
thoughts about the resource. The One Month Post-Viewing Questionnaire
included the repeated measures of the IUS Short Version, GCOS, SSRMI (if the
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participant reported having a child with a mental illness), and Worry scale
(Carleton et al., 2007; Donnellan et al., 2006; Douma, 2010; Heppner et al.,
1995; McAllister et al., 2011).
Interested individuals were invited to click a link to the questionnaire,
which directed them to the study consent form on REDCap (Research Electronic
Data Capture), a secure, online application designed to collect data for research
purposes (Harris et al., 2009; Harris et al., 2019). All participants included in the
study indicated consent to participate. Next, participants were asked to enter
their email address into a REDCap field to allow individual follow-up
questionnaire links and a study honorarium to be sent to them. This study was
done following the review and approval of the University of South Carolina’s
Institutional Review Board (Pro00112654).
2.3.3 Resource Booklet for 22q11.2DS Psychiatric Manifestations
After completing the Pre-Resource Viewing Questionnaire, the participants
were asked to view an educational booklet titled, “22q11.2 Deletion Syndrome:
What does it mean for mental health?” containing 22 pages of patient-friendly
information relevant to mental health conditions seen in 22q11.2DS. This
educational booklet was previously designed during a research study by a
University of British Columbia (UBC) genetic counseling candidate in
collaboration with the psychiatric genetic counseling group at the UBC
Department of Psychiatry (Chieffo, 2018). The content of the booklet was
directed by the input of parents of children with 22q11.2DS who had had
psychiatric genetic counseling. They were initially given a generic mental illness
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booklet and then interviewed to identify what they would like to be included in a
22q11.2DS psychiatric symptom-specific resource. Using the themes from these
interviews, the booklet was created and reassessed by ten parents of children
with the condition. Feedback was obtained, and the resource was further
modified. The booklet contains a description of 22q11.2DS, mental illness, the
causes of mental illness, protective factors in mental illness, mental illness as
seen in 22q11.2DS, and early signs of mental illness. The booklet also provides
a section including mental health resources.
2.3.4 Mini-International Personality Item Pool (Mini-IPIP)
The Mini-IPIP was used in this study to measure personality dimensions
(Donnellan et al., 2006). This scale contains 20 questions in a 5-point Likert scale
fashion (with 1 = “very inaccurate” and 5 = “very accurate”) that measure the “Big
Five” personality traits which are labeled as extraversion, agreeableness,
conscientiousness, neuroticism, and openness to experience. Each personality
trait serves as a subscale and is assigned four questions. Questions 6, 7, 8, 9,
10, 15,16, 17, 18, 19, and 20 were reverse scored as outlined in the directions for
using the scale. The scoring is completed by calculating the sum of responses
within each of the three subscales (Donnellan et al., 2006). The results of this
study demonstrated reliability for each of the factors of extraversion (α = 0.896),
agreeableness (α = 0.794), conscientiousness (α = 0.892), neuroticism (α =
0.731), and openness to experience (α = 0.706).
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2.3.5 Intolerance of Uncertainty Short Version (IUS Short Version)
The IUS Short Version was used to measure participants’ reactions to
ambiguity, uncertainty, and the future. This scale includes 12 questions in a 5point Likert scale fashion (with 1 = “not characteristic of me” and 5 = “entirely
characteristic of me”) and is scored as a total sum of all responses (Carleton et
al., 2007). The results of this study indicated adequate reliability of the scale (α =
0.795).
2.3.6 Problem-Focused Style of Coping (PF-SOC)
The PF-SOC was used to measure coping style, and it included 18
questions in a 5-point Likert scale fashion (with 1 = “almost never” and 5 =
“almost all of the time”) (Heppner et al., 1995). This scale separates coping styles
into reflective, suppressive, and reactive categories. Each of the three coping
styles serves as a subscale with assigned questions. Of the 18 questions, seven
pertain to reflective coping, six to suppressive coping, and five to reactive coping.
The results of this study demonstrated reliability for each of the factors of
reflective coping (α = 0.791), suppressive coping (α = 0.921), and reactive coping
(α = 0.876).
2.3.7 Genetic Counseling Outcome Scale (GCOS)
The GCOS was used to measure the empowerment of the participants
(McAllister et al., 2011). This scale contains 24 questions in a 7-point Likert scale
fashion (with 1 = “strongly agreed” and 7 = “strongly disagree”), and it is scored
as a total sum of all responses. The results of this study indicated adequate
reliability of the scale (α = 0.863).
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2.3.8 Self-Stigma in Relatives of People with Mental Illness Scale (SSRMI)
Participants completed the SSRMI if they reported that their child had a
mental illness. This scale measures the self-stigma of first-degree relatives of
individuals with serious mental illness (Morris et al., 2018). The scale contains
ten questions in a 5-point Likert scale fashion (with 1 = “strongly disagree” and 5
= “strongly agree”) and is scored as a total sum of all responses. The results of
this study indicated adequate reliability of the scale (α = 0.748).
2.3.9 Worry Scale
The Worry scale was used to measure the participants’ level of worry
concerning their child’s chances to have a mental illness, and it was adapted
from the modified cancer worry scale (Douma, 2010). It consisted of 8 questions.
The first question, “How often have you thought about your child’s chance of
getting a mental illness (again)?” was scored on a 4-point scale (with 1 = “never”
and 4 = “almost always”). The second question, “Have these thoughts affected
your mood?” was scored on a 4-point scale (with 1 = “no, not at all” and 4 = “yes,
a lot”). The third question, “Have these thoughts interfered with your ability to do
daily activities?” was scored on the same 4-point scale as the second question.
The fourth question, “How concerned are you about the possibility of your child
getting a mental illness (again) one day?” was scored on a 4-point scale (with 1 =
“not concerned” and 4 = “very concerned”). The fifth question, “How often do you
worry about your child developing a mental illness (again)?” was scored on a 4point scale (with 1 = “never” and 4 = “almost always”). The sixth question, “How
much of a problem is this worry?” was scored on a 4-point scale (with 1 = “not at
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all a problem” and 4 = “very much a problem”). The seventh question, “How
concerned are you about the possibility that your child will ever need treatment
for a mental illness (again)?” was scored on the same 4-point scale as the fifth
question. The scores of each question were combined to create a total worry
score. The results of this study indicated adequate reliability of the scale (α =
0.903).
2.3.10 Data Analysis
All quantitative statistical analyses were completed using the Statistical
Package for the Social Sciences (SPSS). Descriptive statistics were calculated
for the participant demographic information and the Immediate Post-Viewing
Questionnaire. Reliability analyses were run for each scale used in the research
study including the Mini-IPIP, IUS Short Version, GCOS, SSRMI, and Worry
scale. Then a paired sample t-test was run to compare the T1 responses to the
T2 responses. Following this, Pearson’s correlation coefficients were determined
for both the Mini-IPIP and PF-SOC versus the results of the IUS Short version,
GCOS, Worry scale, and SSRMI for both T1 and T2.
The qualitative data collected through the short answer responses on the
Immediate Post-Viewing Questionnaire were analyzed for themes. Themes were
determined for each question based on repetitive answers provided by
participants, and the themes for each of the questions were synthesized to create
three compiled themes.
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2.4 Results
2.4.1 Demographic Information
There was a total of 73 participants included in the study. Demographic
information of the participants can be seen in Table 2.1, participant diagnosis
information can be seen in Table 2.2, and information about the participants’
children can be seen in Table 2.3. Of the 73 participants, 17 said their child
received a diagnosis prenatally (23.3%), while 56 did not receive a diagnosis
prenatally (76.7%). Of the 73, 32 said their child received a diagnosis of
22q11.2DS before the age of 1 (43.8%), 22 said their child did not receive a
diagnosis before the age of 1 (30.1%), and 19 participants did not answer this
question (26.0%). The average age of diagnosis for the children was 6.11 years
old (SD = 7.138). The most frequently reported age of diagnosis was three years
old.
2.4.2 Pre-Viewing versus One Month Post-Viewing (T1 vs T2)
Of the 73 participants, 47 completed the GCOS at T1 and T2, 46
completed the Worry scale at T1 and T2, 17 completed the SSRMI at T1 and T2,
and 9 completed the IUS Short Version at T1 and T2. A two-sided paired sample
t-test was used to compare T1 and T2. The GCOS measure increased from T1
(M = 127.640, SD = 20.231) to T2 (M = 135.043, SD = 19.868), with a difference
in the means of 7.403, 95% CI [-11.401, -3.408], t(47) = -3.729, p < 0.05, d = 0.544 (Figure 2.1). The Worry scale measure decreased from T1 (M = 18.239,
SD = 5.626) to T2 (M = 17.304, SD = 5.028), with a difference in the means of 0.935, 95% CI [-0.00096, 1.871], t(46) = 2.012, p < 0.05, d = 0.297 (Figure 2.2).
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The SSRMI measure had nearly no detected change between T1 (M = 23.471,
SD = 5.433) and T2 (M = 23.294, SD = 8.161), with a difference in the means of 0.177, 95% CI [-2.790, 3.143], t(17) = 0.126, p = 0.90, d = 0.031 (Figure 2.3). The
IUS Short Version measure seemed to decrease from T1 (M = 27.333, SD =
7.583) to T2 (M = 24.889, SD = 7.441), with a difference in the means of -2.444,
95% CI [-0.137, 5.026], t(9) = 2.184, p < 0.05, d = 0.728 (Figure 2.4).
2.4.3 Correlations
After this, Pearson’s correlations were run to look at the relationships
between the Mini-IPIP and PF-SOC versus T1 (IUS Short Version, GCOS, Worry
scale, and SSRMI) and the Mini-IPIP and PF-SOC versus T2 (IUS Short Version,
GCOS, Worry scale, and SSRMI). All 73 participants were included. There were
no statistically significant correlations between Mini-IPIP and PF-SOC versus T1
or the Mini-IPIP and PF-SOC versus T2.
2.4.4 Immediate Post-Viewing Survey
Of the 73 participants, 51 completed the Immediate Post-Viewing Survey.
The majority of participants reported that the booklet was easy to understand
(Figure 2.5), provided them with a better understanding of 22q11.2DS and
mental illness (Figure 2.6), answered questions they had regarding mental illness
associated with 22q11.2DS (Figure 2.7), would be helpful for other families who
have a child with 22q11.2DS (Figure 2.8), helped them understand strategies
they could use to protect their child’s mental health (Figure 2.9), and helped them
to feel more confident in their ability to recognize early warning signs of mental
illness (Figure 2.10). Responses from participants were not uniform when they
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were asked if the resource led them to feel less worried about the risks for
psychiatric disorders in 22q11.2DS (Figure 2.11).
The short answer questions on the Immediate Post-Viewing Questionnaire
were answered by 25 of the participants. Themes were extracted from each
question and then compiled into three major themes, as seen in Table 2.4.
2.5 Discussion and Conclusion
2.5.1 Discussion
The goal of this study was to evaluate the parent perception of a resource
booklet focusing on the psychiatric manifestations of 22q11.2DS. The sample
population was parents of children with 22q11.2DS. This research aimed to
assess the utility of the booklet; to improve awareness and understanding about
the psychiatric manifestations and strategies to protect and improve mental
health; and to evaluate the perceived changes in the parents’ feelings of
empowerment, worry, self-stigma, and perceived ability to deal with the
uncertainty surrounding the mental health of their children. Personality factors
were also examined to determine if they influenced the participants’ responses. It
was hypothesized that the parents would find the resource to be helpful. It was
also hypothesized that different personality characteristics might alter the way
participants interact with the resource.
The study results found that the parents experienced increased
empowerment and decreased worry after reading the resource. The literature
has previously observed the amelioration of feelings within parents after viewing
medical-oriented educational resources pertaining to their children. For example,
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in a study completed by Hunt et al. (2020), it was found that viewing an
educational booklet about congenital heart disease aided in changing the
demeanor of the parents with an affected child. For these parents, parental guilt
was diminished after viewing the resource. The increase in empowerment and
decrease in worry for parents of children with 22q11.2DS could potentially
increase their confidence in their ability to provide care for their child’s needs.
This could be beneficial regarding their status as the caregiver for their child if
this empowerment leads to a subsequential decrease in perceived caregiver
burden. A study by Karas et al. (2014) demonstrated that psychiatric
manifestations of 22q11.2DS are deemed to have a high perceived burden
among caregivers. If this knowledge helps parents feel confident in their abilities
to help their children manage this portion of the condition, this may alleviate this
perceived burden.
The majority of participants in the current study reported that the booklet
was easy to understand, provided them with a better understanding of
22q11.2DS and mental illness, answered questions they had regarding mental
illness associated with 22q11.2DS, would be helpful for other families who have
a child with 22q11.2DS, helped them understand strategies they could use to
protect their child’s mental health, and helped them feel more confident in their
ability to recognize early warning signs of mental illness. This data appeared to
address the concerns raised by parents in a previous study where they
expressed the need for an educational resource that would include education on
early warning signs of psychiatric illness and how to manage their child’s mental
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illness (Alugo et al., 2017). However, responses from participants were not
uniform when they were asked if the resource led them to feel less worried about
the risks for psychiatric disorders in 22q11.2DS. This was interesting since the
participants’ worry decreased from T1 to T2. It could be that the increased time to
process the information in the booklet from the Immediate Post-Viewing
Questionnaire to the One Month Post-Viewing Questionnaire could have aided in
decreasing the worry among the parents. Family members may also still feel
some degree of worry and uncertainty that may be difficult to quantify until
specifically faced with psychiatric illness in their child.
Themes from the Immediate Post-Viewing Questionnaire indicated that
the booklet was easy to understand, helpful, and included useful illustrations; the
booklet could be improved by providing more detailed information and more
mental health resources; and the parents would have wanted to know information
about the psychiatric manifestations of 22q11.2DS at the diagnosis of their child,
but this may be considered overwhelming for other parents. This supported the
hypothesis that parents would find the educational resource helpful. It also
highlighted areas of improvement for the resource. The timing of the delivery of
the information of the psychiatric conditions within 22q11.2DS remained
consistent with the previous literature where parents reported that they would
want to receive this information before the onset of the child’s psychological
symptoms (Martin et al., 2012). Interestingly, the parents involved in this study
expressed their preference to hear about the psychiatric manifestations at the
time of diagnosis. Still, they expressed concern that this may overwhelm other
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parents. This may be due to the parents in this study likely being inherently
information-seeking since they volunteered to contribute to a research study.
They could be recognizing that other parents may not want as much information.
Correlations between different personality factors and responses to the T1
and T2 questionnaires were not statistically significant. This may be due to the
small sample size, or it could suggest that personality factors may not influence
the participants’ responses.
2.5.2 Conclusion
The timing and delivery of information about the psychiatric manifestations
of 22q11.2DS are not standardized among healthcare professionals. This leads
to parents of children with the condition being unaware of the potential for their
child to have a mental illness and less prepared to recognize when their child
needs psychiatric care. This information is best addressed through a consultation
with a psychiatric genetic counselor, but the resources for this service are limited.
In order to address the need for providing this information, an educational
resource booklet was provided to parents of children with 22q11.2DS for
evaluation. It was determined that the booklet increased empowerment among
the parents surrounding the topic and it decreased worry. The parents reported
that the booklet was easy to understand, provided them with a better
understanding of 22q11.2DS and mental illness, answered questions they had
about mental illness associated with the condition, would be helpful for other
families who have a child with the condition, helped them understand strategies
they could use to protect their child’s mental health, and helped them feel more
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confident in their ability to recognize early warning signs of mental illness. The
parents suggested that the booklet be improved with more detailed information
and additional mental health resources. This study also revealed that the parents
would have preferred to hear about the psychiatric manifestations of the
condition at the time of diagnosis of their child; however, the sampled parents
emphasized that other parents may feel overwhelmed with this same timing.
2.5.3 Practice Implications
Based on the results of this study, there could be a potential benefit in
distributing this booklet to other parents of children with 22q11.2DS. Providing
this resource to parents of children with 22q11.2DS would allow access to
medically sourced information rather than unregulated information sources such
as the internet. In addition, the resource addresses multiple previously identified
parent concerns by highlighting signs of emerging mental illness and mental
health management. This booklet would not replace psychiatric genetic
counseling services, but it could aid in addressing the current limited availability
of this specialized service (Inglis et al., 2015).
2.5.4 Limitations and Future Research
Limitations of the study include the participant population and the small
sample size. The participants consisted mainly of white females and individuals
of higher education levels (the most frequently reported terminal degree was a
bachelor’s degree followed by a master’s degree). It would be interesting to
pursue further research to determine if the perspectives represented in the
findings of this study would change with populations that include more males and

36

individuals with different ethnic and educational backgrounds. The study
population also likely consisted of participants who are more prone to seek
information since they volunteered to be involved in a research study. The
viewpoints of other parents who prefer to know less information may not have
been represented as prominently. The statistical analysis of this study was
limited due to the small sample size. Additional data could be collected in the
future for further analysis.
Future studies could be completed to refine the educational resource
following the suggestions submitted by the parents. There were requests for
more detailed information and support resources to be included in the booklet.
Further examination could also be completed to determine any moderators that
may affect the perception of the resource’s utility. Personality factors were not
found to be moderating variables in this study, but additional avenues may be
explored. Another area of further research could address the timing of the
provision of the resource to families. The participants reported that they were
unsure if other parents would want this information during the diagnosis. A study
could be completed with two cohorts where one is given the booklet at the time of
the diagnosis and the other is given the booklet at a later stage.
Table 2.1 Participant Demographics
Participant characteristic
Age
20-24
25-30
31-35
36-40
41-45
46-50
37

Total (n)

Percent (%)

2
0
11
27
8
9

2.7
0
15.1
37.0
11.0
12.3

51-55
56-60
61-65
66-70

8
3
4
1

11.0
4.1
5.5
1.4

7
66

9.6
90.4

63
1
3
3
3

86.3
1.4
4.1
4.1
4.1

1
66
4
1
1

1.4
90.4
5.5
1.4
1.4

3

4.1

5

6.8

7

9.6

8

11.0

27
18
5

37.0
24.7
6.8

Sex
Male
Female
Ethnicity
White/Caucasian/European
Black or African American
Hispanic or Latino
Asian
Other
Location
Canada
United States
Europe
Asia
Australia/South Pacific
Education
Some high school, no
diploma
High school graduate,
diploma, or equivalent
(e.g., GED)
Some college credit, no
degree
Trade/technical vocational
training
Bachelor’s degree
Master’s degree
Doctorate

Table 2.2 Participant Diagnoses Information
Participant’s diagnosis
status
Diagnosed with 22q11.2DS
Yes
No
Unspecified
Diagnosed with a mental
illness
Yes
No

Total (n)

Percent (%)

3
31
39

4.1%
42.5%
53.4%

20
53

27.4
72.6
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Table 2.3 Demographics and Diagnoses Information of the Children
Information about child

Total (N)

Percent (%)

Age
0-5
22
30.1
6-10
14
19.2
11-15
10
13.7
16-20
10
13.7
21-25
7
9.6
26-30
1
1.4
31-35
2
2.7
36-40
3
4.1
Unspecified
4
5.5
Age when diagnosed with 22q11.2DS
0-5
15
20.5
6-10
6
8.2
11-15
0
0
16-20
0
0
21-25
0
0
26-30
0
0
31-35
0
0
36-40
1
1.4
Unspecified
51
69.9
Diagnosed with a mental illness
Yes
29
39.7
No
44
60.3
Mental illness diagnosis*
Anxiety
26
35.6
Depression
12
16.4
Schizophrenia
2
2.7
Obsessive-Compulsive Disorder
11
15.1
(OCD)
Bipolar Disorder
4
5.5
Other psychiatric diagnoses
8
11.0
Treatment received for psychiatric diagnosis
Yes
26
35.6
No
3
4.1
Unspecified
44
60.3
Mental health assessment
Yes
8
11.0
No
36
49.3
Unspecified
29
39.7
*This category is a question for which participants could select more than one
answer. Due to this, the percentages do not reach a sum of 100%.
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Table 2.4 Short Response Themes for Immediate Post-Viewing Survey
Question
What did you like
about the
booklet?

What did you not
like about the
booklet?

Please comment
on when you think
this resource
should be given
to parents of
children with
22q11.2DS.

Was there
anything that you
felt was missing
from the booklet?

If you have any
additional
thoughts or
comments about
the booklet,
please write them
here.

Themes
1) The booklet was easy
to understand.
2) The illustration of the jar
model was appreciated.
1) The participants would
have liked to see
missing pieces of
information included.
2) The booklet should
provide links to mental
health resources.
1) This resource should be
given to parents of
children with
22q11.2DS at
diagnosis.
2) For families of children
with 22q11.2DS, this
resource should be
provided before the
teenage years.
1) The resource should
focus more on providing
strategies for protecting
against mental illness in
childhood.
1) More details could have
been included in the
booklet.
2) The resource could
possibly overwhelm
parents with younger
and newly diagnosed
children.
3) The booklet was
appreciated and
thought to be helpful.
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Compiled Themes
1) The booklet was
easy to
understand,
helpful, and
included
illustrations that
were useful.
2) The booklet could
be improved by
providing more
detailed
information and
more mental
health resources.
3) The parents
expressed that
they would have
wanted to know
this information
when their child
was first
diagnosed with
22q11.2DS, but
they recognized
that this may be
too overwhelming
for other parents.

Mean GCOS Scores from T1 versus T2
136
134

Mean

132
130
128
126
124
122
GCOS T1

GCOS T2
Time Period

Figure 2.1 Comparison of the mean GCOS scores from T1 versus T2.

Mean Worry Scale Scores from T1 versus T2
18.4
18.2
18

Mean

17.8
17.6
17.4
17.2
17
16.8
Worry scale T1

Worry scale T2
Time Period

Figure 2.2 Comparison of the mean Worry scale scores from T1 versus T2.
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Mean SSRMI Scores from T1 versus T2
23.5
23.45

Mean

23.4
23.35
23.3
23.25
23.2

SSRMI T1

SSRMI T2
Time Period

Figure 2.3 Comparison of the mean SSRMI scores from T1 versus T2
Mean IUS Short Version Scores from T1 versus T2
28
27.5
27

Mean

26.5
26
25.5
25
24.5
24
23.5
IUS Short Version T1

IUS Short Version T2
Time Period

Figure 2.4 Comparison of the mean IUS Short Version scores from T1 versus T2
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Answers to Question One: "The information in the booklet was easy to
understand."
2.0%

35.3%

62.7%

Strongly Agree

Agree

Niether Agree Nor Disagree

Disagree

Strongly Disagree

Figure 2.5 Percentage of participants stating strongly agree, agree, disagree,
neither agree nor disagree, disagree, or strongly disagree in response to
Immediate Post-Viewing Questionnaire question one, “The information in the
booklet was easy to understand.”
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Answers to Question Two: "I feel I have a better understanding of 22q11.2
deletion syndrome and mental illness after reading this booklet."
2.0%

27.5%

37.3%

33.3%

Strongly Agree

Agree

Niether Agree Nor Disagree

Disagree

Strongly Disagree

Figure 2.6 Percentage of participants stating strongly agree, agree, disagree,
neither agree nor disagree, disagree, or strongly disagree in response to
Immediate Post-Viewing Questionnaire question two, “I feel I have a better
understanding of 22q11.2 deletion syndrome and mental illness after reading this
booklet.”

44

Answers to Question Three: "This booklet answered questions I had regarding
mental illness associated with 22q11.2 deletion syndrome."

5.9%
25.5%
21.6%

47.1%

Strongly Agree

Agree

Niether Agree Nor Disagree

Disagree

Strongly Disagree

Figure 2.7 Percentage of participants stating strongly agree, agree, disagree,
neither agree nor disagree, disagree, or strongly disagree in response to
Immediate Post-Viewing Questionnaire question three, “This booklet answered
questions I had regarding mental illness associated with 22q11.2 deletion
syndrome.”
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Answers to Question Four: "I feel this booklet would be helpful for other
families who have a child with 22q11.2 deletion syndrome."
2.0%
7.8%

52.9%

37.3%

Strongly Agree

Agree

Niether Agree Nor Disagree

Disagree

Strongly Disagree

Figure 2.8 Percentage of participants stating strongly agree, agree, disagree,
neither agree nor disagree, disagree, or strongly disagree in response to
Immediate Post-Viewing Questionnaire question four, “I feel this booklet would
be helpful for other families who have a child with 22q11.2 deletion syndrome.”
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Answers to Question Five: "I feel this booklet helped me understand strategies
that can be used to protect my child's mental health."
2.0% 2.0%

17.6%

29.4%

49.0%

Strongly Agree

Agree

Niether Agree Nor Disagree

Disagree

Strongly Disagree

Figure 2.9 Percentage of participants stating strongly agree, agree, disagree,
neither agree nor disagree, disagree, or strongly disagree in response to
Immediate Post-Viewing Questionnaire question five, “I feel this booklet helped
me understand strategies that can be used to protect my child’s mental health.”
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Answers to Question Seven: "The booklet helped me to feel more confident in
my ability to recognize early warning signs of mental illness."
2.0% 2.0%

15.7%

29.4%

51.0%

Strongly Agree

Agree

Niether Agree Nor Disagree

Disagree

Strongly Disagree

Figure 2.10 Percentage of participants stating strongly agree, agree, disagree,
neither agree nor disagree, disagree, or strongly disagree in response to
Immediate Post-Viewing Questionnaire question seven, “The booklet helped me
to feel more confident in my ability to recognize early warning signs of mental
illness.”
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Answers to Question Six: "I feel less worried about the risks for psychiatric
disorders in 22q11.2 deletion syndrome after reading through this booklet."

5.9%

19.6%
19.6%

25.5%
29.4%

Strongly Agree

Agree

Niether Agree Nor Disagree

Disagree

Strongly Disagree

Figure 2.11 Percentage of participants stating strongly agree, agree, disagree,
neither agree nor disagree, disagree, or strongly disagree in response to
Immediate Post-Viewing Questionnaire question six, “I feel less worried about the
risks for psychiatric disorders in 22q11.2 deletion syndrome after reading through
this booklet.”
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CHAPTER 3
CONCLUSIONS
The timing and delivery of information about the psychiatric manifestations
of 22q11.2DS are not standardized among healthcare professionals. This leads
to parents of children with the condition being unaware of the potential for their
child to have a mental illness and less prepared to recognize when their child
needs psychiatric care. This information is best addressed through a consultation
with a psychiatric genetic counselor, but the resources for this service are limited.
In order to address the need for providing this information, an educational
resource booklet was created. This booklet outlines what mental illness is, its
causes, mental illness as seen in 22q11.2DS, protective factors, mental health
resources, and early signs of mental illness. The booklet was presented to
parents of children with the condition to determine whether it would be suitable
for other parents. The perceptions and feedback of the parents were collected
through a series of questionnaires. It was determined that the booklet increased
empowerment among the parents surrounding the topic, and it decreased worry.
It was also found that the parents thought that the booklet was easy to
understand, provided them with a better understanding of 22q11.2DS and mental
illness, answered questions they had about mental illness associated with the
condition, would be helpful for other families who have a child with the condition,
helped them understand strategies they could use to protect their child’s mental
50

health, and helped them feel more confident in their ability to recognize early
warning signs of mental illness. The parents suggested that the booklet be
improved with more detailed information and additional mental health resources.
This study also revealed that the parents would have preferred to hear about the
psychiatric manifestations of the condition at the time of diagnosis of their child;
however, the sampled parents emphasized that other parents may feel
overwhelmed with this same timing. Based on the results of this study, it may
suggest a benefit in distributing this booklet to other parents of children with
22q11.2DS. Providing this resource would allow parents to access this
information through a trusted medical source rather than unregulated information
sources such as the internet.
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APPENDIX A
STUDY CONSENT FORM
The participants were required to view and electronically consent before they
were included in the study. The consent form is included below.
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Figure A.1 Study consent form.
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APPENDIX B
STUDY QUESTIONNAIRES
The following questionnaires were administered to the participants.
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Imagination.
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Figure B.1 Pre-Viewing Questionnaire (T1).
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Figure B.2 Immediate Post-Viewing Questionnaire.
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Imagination.
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Figure B.3 One Month Post-Viewing Questionnaire.
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APPENDIX C
EDUCATIONAL RESOURCE BOOKLET
The resource booklet used in the study is pictured below.
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Figure C.1 Educational Resource Booklet for 22q11.2DS psychiatric symptoms.
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APPENDIX D
PEARSON’S CORRELATION DATA
The raw data for the Pearson’s correlations are included below.
Table D.1 Mini-IPIP versus All T1 Variables
Extraver Agreea Conscien Neurotic
sion
bleness tiousness
ism
Pearson
Correlation

1

Extraver
sion
Sig. (2-tailed)

Openness
to
Experience

.570

.246

-.133

-.381

.086

.493

.714

.278

N

10

10

10

10

10

Pearson
Correlation

.570

1

.336

.068

-.140

.343

.851

.700

Agreeab
leness Sig. (2-tailed)

.086

N

10

10

10

10

10

Pearson
Correlation

.246

.336

1

-.475

-.141

.493

.343

.166

.697

10

10

10

10

10

-.133

.068

-.475

1

.681*

.714

.851

.166

10

10

10

Conscie
ntiousne Sig. (2-tailed)
ss
N
Pearson
Correlation

Neurotici
sm
Sig. (2-tailed)
N

99

.030
10

10

Pearson
Openne
Correlation
ss to
Experien Sig. (2-tailed)
ce
N

IUS
TOTAL
1

-.381

-.140

-.141

.681*

.278

.700

.697

.030

10

10

10

10

10

Pearson
Correlation

.277

.145

.014

.562

.219

Sig. (2-tailed)

.439

.689

.970

.091

.543

N

10

10

10

10

10

.129

-.068

.653*

-.651*

-.279

.723

.852

.041

.041

.434

10

10

10

10

10

-.132

.079

-.586

.677*

.290

.717

.828

.075

.031

.416

10

10

10

10

10

-.336

-.038

-.601

.856**

.494

.343

.917

.066

.002

.147

10

10

10

10

10

-.336

.413

.313

-.329

-.289

.343

.235

.379

.353

.418

10

10

10

10

10

.189

-.866

-.655

.000

-.569

.879

.333

.546

1.000

.614

3

3

3

3

3

Pearson
PFCorrelation
SOC:
Reflectiv Sig. (2-tailed)
e
N
Pearson
PFCorrelation
SOC:
Suppres Sig. (2-tailed)
sive
N
Pearson
Correlation

PFSOC:
Sig. (2-tailed)
Reactive
N
Pearson
Correlation
imputed
_total_g Sig. (2-tailed)
cos_t1
N
Pearson
Correlation

Stigma
Total
Sig. (2-tailed)
Preview
N

100

1

Pearson
Correlation

Worry
Total
Sig. (2-tailed)
Preview
N

-.164

-.115

.527

.002

-.001

.651

.751

.117

.996

.999

10

10

10

10

10

*. Correlation is significant at the 0.05 level (2-tailed).
**. Correlation is significant at the 0.01 level (2-tailed).
Table D.2 T1 IUS, PF-SOC, and GCOS versus All T1 Variables

IUS
TOTAL
1

PF-SOC:
Reflective

.277

.129

-.132

-.336

-.336

.439

.723

.717

.343

.343

N

10

10

10

10

10

Pearson
Correlation

.145

-.068

.079

-.038

.413

.689

.852

.828

.917

.235

N

10

10

10

10

10

Pearson
Correlation

.014

.653*

-.586

-.601

.313

.970

.041

.075

.066

.379

10

10

10

10

10

.562

-.651*

.677*

.856**

-.329

.091

.041

.031

.002

.353

N

10

10

10

10

10

Pearson
Correlation

.219

-.279

.290

.494

-.289

Pearson
Correlation

Extraver
sion
Sig. (2-tailed)

Agreeab
leness Sig. (2-tailed)

Conscie
ntiousne
Sig. (2-tailed)
ss
N
Pearson
Correlation

Neurotici
sm
Sig. (2-tailed)

Openne
ss to
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PF-SOC:
PF-SOC: imputed
Suppress
Reactive _total_g
ive
cos_t1

Experien Sig. (2-tailed)
ce
N

IUS
TOTAL
1

Pearson
Correlation

.543

.434

.416

.147

.418

10

10

10

10

10

1

-.470

.476

.551

-.412

.171

.164

.099

.236

10

10

10

10

10

-.470

1

-.650*

-.788**

.161

.042

.007

.656

Sig. (2-tailed)
N

Pearson
PFCorrelation
SOC:
Reflectiv Sig. (2-tailed)
e
N
Pearson
PFCorrelation
SOC:
Suppres Sig. (2-tailed)
sive
N
Pearson
Correlation

PFSOC:
Sig. (2-tailed)
Reactive
N
Pearson
Correlation
imputed
_total_g Sig. (2-tailed)
cos_t1
N
Pearson
Correlation

Stigma
Total
Sig. (2-tailed)
Preview
N
Pearson
Correlation

.171
10

10

10

10

10

.476

-.650*

1

.904**

-.096

.164

.042

<.001

.792

10

10

10

10

10

.551

-.788**

.904**

1

-.123

.099

.007

<.001

10

10

10

10

10

-.412

.161

-.096

-.123

1

.236

.656

.792

.736

10

10

10

10

73

-.240

.056

.228

.108

-.417*

.846

.964

.854

.931

.027

3

3

3

3

28

.408

.168

-.026

.056

-.231

102

.736

Worry Sig. (2-tailed)
Total
N
Preview

.242

.642

.943

.877

.053

10

10

10

10

71

*. Correlation is significant at the 0.05 level (2-tailed).
**. Correlation is significant at the 0.01 level (2-tailed).
Table D.3 T1 SSRMI and Worry Scale versus All T1 Variables

Extraversion

Agreeableness

Conscientiousness

Neuroticism

Openness to
Experience

IUS TOTAL 1

Stigma Total
Preview

Worry Total
Preview

Pearson Correlation

.189

-.164

Sig. (2-tailed)

.879

.651

N

3

10

Pearson Correlation

-.866

-.115

Sig. (2-tailed)

.333

.751

N

3

10

Pearson Correlation

-.655

.527

Sig. (2-tailed)

.546

.117

N

3

10

Pearson Correlation

.000

.002

Sig. (2-tailed)

1.000

.996

N

3

10

Pearson Correlation

-.569

-.001

Sig. (2-tailed)

.614

.999

N

3

10

Pearson Correlation

-.240

.408

Sig. (2-tailed)

.846

.242

N

3

10

Pearson Correlation

.056

.168

103

Sig. (2-tailed)

.964

.642

N

3

10

Pearson Correlation

.228

-.026

Sig. (2-tailed)

.854

.943

N

3

10

Pearson Correlation

.108

.056

Sig. (2-tailed)

.931

.877

N

3

10

Pearson Correlation

-.417*

-.231

Sig. (2-tailed)

.027

.053

N

28

71

Pearson Correlation

1

.157

PF-SOC:
Reflective

PF-SOC:
Suppressive

PF-SOC: Reactive

imputed_total_gco
s_t1

Stigma Total
Preview

Sig. (2-tailed)

.445

N

28

26

Pearson Correlation

.157

1

Sig. (2-tailed)

.445

N

26

Worry Total
Preview

71

*. Correlation is significant at the 0.05 level (2-tailed).
**. Correlation is significant at the 0.01 level (2-tailed).
Table D.4 PF-SOC versus All T2 Variables
Extraver Agreeable Conscient Neurotic
sion
ness
iousness
ism
Pearson
Extraversi Correlation
on
Sig. (2tailed)

1

Openness
to
Experience

.570

.246

-.133

-.381

.086

.493

.714

.278

104

Agreeable
ness

Conscienti
ousness

Neuroticis
m

N

10

10

10

10

10

Pearson
Correlation

.570

1

.336

.068

-.140

Sig. (2tailed)

.086

.343

.851

.700

N

10

10

10

10

10

Pearson
Correlation

.246

.336

1

-.475

-.141

Sig. (2tailed)

.493

.343

.166

.697

N

10

10

10

10

10

Pearson
Correlation

-.133

.068

-.475

1

.681*

Sig. (2tailed)

.714

.851

.166

N

10

10

10

10

10

-.381

-.140

-.141

.681*

1

.278

.700

.697

.030

10

10

10

10

10

Pearson
Correlation

-.123

.072

.083

-.384

.032

Sig. (2tailed)

.735

.843

.821

.273

.929

N

10

10

10

10

10

.001

-.171

-.016

.354

.144

.999

.636

.966

.315

.691

Pearson
Openness Correlation
to
Sig. (2Experienc
tailed)
e
N

GCOS
Time 2

Pearson
Worry
Correlation
Total Time
Sig. (22
tailed)

105

.030

IUS Time
2

Stigma
Time 2

N

10

10

10

10

10

Pearson
Correlation

.304

.047

.217

.541

.321

Sig. (2tailed)

.427

.904

.574

.133

.400

N

9

9

9

9

9

Pearson
Correlation

.982

-.500

.756

-1.000**

-.822

Sig. (2tailed)

.121

.667

.454

.000

.386

N

3

3

3

3

3

*. Correlation is significant at the 0.05 level (2-tailed).
**. Correlation is significant at the 0.01 level (2-tailed).
Table D.5 All T2 Variables versus Mini-IPIP and All T2 Variables
GCOS Worry Total IUS
Time 2
Time 2
Time 2

Extraversion

Agreeableness

Conscientiousness

Stigma
Time 2

Pearson
Correlation

-.123

.001

.304

.982

Sig. (2-tailed)

.735

.999

.427

.121

N

10

10

9

3

Pearson
Correlation

.072

-.171

.047

-.500

Sig. (2-tailed)

.843

.636

.904

.667

N

10

10

9

3

Pearson
Correlation

.083

-.016

.217

.756

Sig. (2-tailed)

.821

.966

.574

.454

N

10

10

9

3

106

Neuroticism

Openness to
Experience

GCOS Time 2

Worry Total Time 2

IUS Time 2

Stigma Time 2

Pearson
Correlation

-.384

.354

.541

-1.000**

Sig. (2-tailed)

.273

.315

.133

.000

N

10

10

9

3

Pearson
Correlation

.032

.144

.321

-.822

Sig. (2-tailed)

.929

.691

.400

.386

N

10

10

9

3

Pearson
Correlation

1

-.308*

-.440

-.488*

.035

.236

.040

Sig. (2-tailed)
N

47

47

9

18

Pearson
Correlation

-.308*

1

.512

-.031

Sig. (2-tailed)

.035

.158

.904

N

47

47

9

18

Pearson
Correlation

-.440

.512

1

-1.000**

Sig. (2-tailed)

.236

.158

N

9

9

9

3

Pearson
Correlation

-.488*

-.031

1.000**

1

Sig. (2-tailed)

.040

.904

.000

N

18

18

3

*. Correlation is significant at the 0.05 level (2-tailed).
**. Correlation is significant at the 0.01 level (2-tailed).
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.000
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APPENDIX E
STUDY FLYER
A flyer was distributed by social media for recruitment.

Figure E.1 Study Flyer.
108

APPENDIX F
PARTICIPANT LETTER
The following letter was sent to potential participants through the Greenwood
Genetic Center.

109

Figure F.1 Potential Participant Letter.
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